Changes in glucose-6-phosphate dehydrogenase expression results in altered behavior of HBV-associated liver cancer cells

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 307, Issue 6, 2014, Pages G611-G622

  Hu, Huaidong ^a,b   Ding, Xiangchun ^a,c   Yang, Yixuan ^a   Zhang, Hongmin ^a   Li, Hong ^a   Tong, Shiwen ^a   An, Xuan ^a   Zhong, Qing ^a   Liu, Xiaoyan ^c   Ma, Lina ^c   Liu, Qing ^c   Liu, Bin ^c   Lu, Zhenhui ^c   Zhang, Dazhi ^a,b   Hu, Peng ^a,b   Ren, Hong ^a,b  

^a THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

^c NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

G6PD; HBV; HCC; ITRAQ; Proteomics

Indexed keywords

4 HYDROXYPHENYLPYRUVATE DIOXYGENASE; ALCOHOL DEHYDROGENASE 1B; ALCOHOL DEHYDROGENASE 1C; ALDEHYDE DEHYDROGENASE ISOENZYME 1; ALPHA1 INTERFERON; APOLIPOPROTEIN E; BETA1 INTERFERON; CALCYCLIN; CYSTATIN B; CYTOCHROME P450 1A2; DIMETHYLANILINE MONOOXYGENASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLYCOGEN PHOSPHORYLASE; GLYCOGEN PHOSPHORYLASE LIVER FORM ISOFORM 2; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 90 BETA; HISTONE H4; INITIATION FACTOR 2ALPHA; INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NUCLEOPHOSMIN; PEROXIDASE; PROTEIN; PROTEIN S100 A11; SERPIN H1; STIP1 PROTEIN; TRANSKETOLASE; UNCLASSIFIED DRUG; VILLIN; VILLIN 1; XYLULOSE REDUCTASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LIVER CANCER CELL LINE; LIVER CELL CARCINOMA; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VERY ELDERLY; VIRUS REPLICATION; CELL MOTION; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HCC; HEPATITIS B; HEPG2 CELL LINE; ITRAQ; LIQUID CHROMATOGRAPHY; LIVER TUMOR; METABOLISM; METHODOLOGY; PATHOLOGY; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; TISSUE MICROARRAY; TUMOR INVASION; VIROLOGY; WESTERN BLOTTING;

G6PD; HBV; HCC; ITRAQ; PROTEOMICS;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; CHROMATOGRAPHY, LIQUID; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSEPHOSPHATE DEHYDROGENASE; HEP G2 CELLS; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE I; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROTEOMICS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TANDEM MASS SPECTROMETRY; TISSUE ARRAY ANALYSIS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; VIRUS REPLICATION;

EID: 84908547778     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00160.2014     Document Type: Article

References (55)

1. Baba M, Yamamoto R, Iishi H, Tatsuta M, Wada A. Role of glucose-6-phosphate dehydrogenase on enhanced proliferation of pre-neoplastic and neoplastic cells in rat liver induced by N-nitrosomorpholine. Int J Cancer 43:892–895, 1989.
2. Block TM, Comunale MA, Lowman M, Steel LF, Romano PR, Fim-mel C, Tennant BC, London WT, Evans AA, Blumberg BS, Dwek RA, Mattu TS, Mehta AS. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc Natl Acad Sci USA 102:779–784, 2005.
3. Boros LG, Puigjaner J, Cascante M, Lee WN, Brandes JL, Bassilian S, Yusuf FI, Williams RD, Muscarella P, Melvin WS, Schirmer WJ. Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. Cancer Res 57:4242–4248, 1997.
4. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer:worldwide incidence and trends. Gastroenterology 127:S5–S16, 2004.
5. Bravard A, Hoffschir F, Ricoul M, Cassingena R, Estrade S, Luccioni C, Dutrillaux B. Alterations of the glutathione cycle enzymes during and after SV40-transformation of human fibroblasts. Carcinogenesis 14:21–24, 1993.
6. Cha C, DeMatteo RP, Blumgart LH. Surgery and ablative therapy for hepatocellular carcinoma. J Clin Gastroenterol 35:S130–S137, 2002.
7. Chao YC, Huang CS, Lee CN, Chang SY, King CC, Kao CL. Higher infection of dengue virus serotype 2 in human monocytes of patients with G6PD deficiency. PloS One 3:e1557, 2008.
8. Chen Y, Choong LY, Lin Q, Philp R, Wong CH, Ang BK, Tan YL, Loh MC, Hew CL, Shah N, Druker BJ, Chong PK, Lim YP. Differential expression of novel tyrosine kinase substrates during breast cancer development. Mol Cell Proteomics 6:2072–2087, 2007.
9. Chong PK, Lee H, Zhou J, Liu SC, Loh MC, So JB, Lim KH, Yeoh KG, Lim YP. Reduced plasma APOA1 level is associated with gastric tumor growth in MKN45 mouse xenograft model. J Proteomics 73:1632–1640, 2010.
10. Cui F, Wang Y, Wang J, Wei K, Hu J, Liu F, Wang H, Zhao X, Zhang X, Yang X. The up-regulation of proteasome subunits and lysosomal proteases in hepatocellular carcinomas of the HBx gene knockin trans-genic mice. Proteomics 6:498–504, 2006.
11. Cui JF, Liu YK, Pan BS, Song HY, Zhang Y, Sun RX, Chen J, Feng JT, Tang ZY, Yu YL, Shen HL, Yang PY. Differential proteomic analysis of human hepatocellular carcinoma cell line metastasis-associated proteins. J Cancer Res Clin Oncol 130:615–622, 2004.
12. Ding SJ, Li Y, Tan YX, Jiang MR, Tian B, Liu YK, Shao XX, Ye SL, Wu JR, Zeng R, Wang HY, Tang ZY, Xia QC. From proteomic analysis to clinical significance:overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis. Mol Cell Proteomics 3:73–81, 2004.
13. El-Rifai W, Moskaluk CA, Abdrabbo MK, Harper J, Yoshida C, Riggins GJ, Frierson HF Jr, Powell SM. Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res 62:6823–6826, 2002.
14. Friel H, Lederman H. A nutritional supplement formula for influenza A (H5N1) infection in humans. Med Hypotheses 67:578–587, 2006.
15. Fu WM, Zhang JF, Wang H, Xi ZC, Wang WM, Zhuang P, Zhu X, Chen SC, Chan TM, Leung KS, Lu G, Xu HX, Kung HF. Heat shock protein 27 mediates the effect of 1,3,5-trihydroxy-13,13-dimethyl-2H-pyran [7,6-b] xanthone on mitochondrial apoptosis in hepatocellular carcinoma. J Proteomics 75:4833–4843, 2012.
16. Fujii K, Kondo T, Yokoo H, Yamada T, Iwatsuki K, Hirohashi S. Proteomic study of human hepatocellular carcinoma using two-dimensional difference gel electrophoresis with saturation cysteine dye. Proteomics 5:1411–1422, 2005.
17. Furuta E, Okuda H, Kobayashi A, Watabe K. Metabolic genes in cancer:their roles in tumor progression and clinical implications. Biochim Biophys Acta 1805:141–152, 2010.
18. Gan CS, Chong PK, Pham TK, Wright PC. Technical, experimental, and biological variations in isobaric tags for relative and absolute quantitation (iTRAQ). J Proteome Res 6:821–827, 2007.
19. Gorg A, Obermaier C, Boguth G, Harder A, Scheibe B, Wildgruber R, Weiss W. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21:1037–1053, 2000.
20. Ho HY, Cheng ML, Weng SF, Chang L, Yeh TT, Shih SR, Chiu DT. Glucose-6-phosphate dehydrogenase deficiency enhances enterovirus 71 infection. J Gen Virol 89:2080–2089, 2008.
21. Ho J, Kong JW, Choong LY, Loh MC, Toy W, Chong PK, Wong CH, Wong CY, Shah N, Lim YP. Novel breast cancer metastasis-associated proteins. J Proteome Res 8:583–594, 2009.
22. Hu T, Zhang C, Tang Q, Su Y, Li B, Chen L, Zhang Z, Cai T, Zhu Y. Variant G6PD levels promote tumor cell proliferation or apoptosis via the STAT3/5 pathway in the human melanoma xenograft mouse model. BMC Cancer 13:251, 2013.
23. Koudstaal J, Makkink B, Overdiep SH. Enzyme histochemical pattern in human tumours. II. Oxidoreductases in carcinoma of the colon and the breast. Eur J Cancer 11:111–115, 1975.
24. Kuo W, Lin J, Tang TK. Human glucose-6-phosphate dehydrogenase (G6PD) gene transforms NIH 3T3 cells and induces tumors in nude mice. Int J Cancer 85:857–864, 2000.
25. Kuo WY, Tang TK. Effects of G6PD overexpression in NIH3T3 cells treated with tert-butyl hydroperoxide or paraquat. Free Radic Biol Med 24:1130–1138, 1998.
26. Kuramitsu Y, Takashima M, Yokoyama Y, Iizuka N, Tamesa T, Akada JK, Wang Y, Toda T, Sakaida I, Okita K, Oka M, Nakamura K. Up-regulation of 42 kDa tubulin alpha-6 chain fragment in well-differentiated hepatocellular carcinoma tissues from patients infected with hepatitis C virus. Anticancer Res 31:3331–3336, 2011.
27. Liang RC, Neo JC, Lo SL, Tan GS, Seow TK, Chung MC. Proteome database of hepatocellular carcinoma. J Chromatogr B Analyt Technol Biomed Life Sci 771:303–328, 2002.
28. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C(T)) Method. Methods 25:402–408, 2001.
29. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 362:1907–1917, 2003.
30. Moradpour D, Wands JR. The molecular pathogenesis of hepatocellular carcinoma. J Viral Hepat 1:17–31, 1994.
31. Mori M, Shimada H, Gunji Y, Matsubara H, Hayashi H, Nimura Y, Kato M, Takiguchi M, Ochiai T, Seki N. S100A11 gene identified by in-house cDNA microarray as an accurate predictor of lymph node metastases of gastric cancer. Oncol Rep 11:1287–1293, 2004.
32. Noori-Daloii MR, Daneshpajooh M. Molecular basis of G6PD deficiency:current status and its perspective. Acta Medica Iranica 46:167–182, 2008.
33. Ou K, Seow TK, Liang RC, Ong SE, Chung MC. Proteome analysis of a human heptocellular carcinoma cell line, HCC-M:an update. Electrophoresis 22:2804–2811, 2001.
34. Pandolfi PP, Sonati F, Rivi R, Mason P, Grosveld F, Luzzatto L. Targeted disruption of the housekeeping gene encoding glucose 6-phos-phate dehydrogenase (G6PD):G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress. EMBO J 14:5209–5215, 1995.
35. Pierce A, Unwin RD, Evans CA, Griffiths S, Carney L, Zhang L, Jaworska E, Lee CF, Blinco D, Okoniewski MJ, Miller CJ, Bitton DA, Spooncer E, Whetton AD. Eight-channel iTRAQ enables comparison of the activity of six leukemogenic tyrosine kinases. Mol Cell Proteomics 7:853–863, 2008.
36. Salvemini F, Franze A, Iervolino A, Filosa S, Salzano S, Ursini MV. Enhanced glutathione levels and oxidoresistance mediated by increased glucose-6-phosphate dehydrogenase expression. J Biol Chem 274:2750–2757, 1999.
37. Sells MA, Chen ML, Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA 84:1005–1009, 1987.
38. Senft C, Priester M, Polacin M, Schroder K, Seifert V, Kogel D, Weissenberger J. Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells. J Neurooncol 101:393–403, 2011.
39. Seow TK, Ong SE, Liang RC, Ren EC, Chan L, Ou K, Chung MC. Two-dimensional electrophoresis map of the human hepatocellular carcinoma cell line, HCC-M, and identification of the separated proteins by mass spectrometry. Electrophoresis 21:1787–1813, 2000.
40. Song HY, Liu YK, Feng JT, Cui JF, Dai Z, Zhang LJ, Feng JX, Shen HL, Tang ZY. Proteomic analysis on metastasis-associated proteins of human hepatocellular carcinoma tissues. J Cancer Res Clin Oncol 132:92–98, 2006.
41. Sun W, Xing B, Sun Y, Du X, Lu M, Hao C, Lu Z, Mi W, Wu S, Wei H, Gao X, Zhu Y, Jiang Y, Qian X, He F. Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electropho-resis:novel protein markers in hepatocellular carcinoma tissues. Mol Cell Proteomics 6:1798–1808, 2007.
42. Tang ZY. Hepatocellular carcinoma—cause, treatment and metastasis. World J Gastroenterol 7:445–454, 2001.
43. Tong SW, Yang YX, Hu H., An X, Ye F, Ren H, Li SL, Zhang DZ. HSPB1 is an intracellular antiviral factor against hepatitis B virus. J Cell Biochem 114:162–173, 2013.
44. Tsouko E, Khan AS, White MA, Han JJ, Shi Y, Merchant FA, Sharpe MA, Xin L, Frigo DE. Regulation of the pentose phosphate pathway by an androgen receptor-mTOR-mediated mechanism and its role in prostate cancer cell growth. Oncogenesis 3:e103, 2014.
45. Wang LN, Tong SW, Hu H., Ye F, Li SL, Ren H, Zhang DZ, Xiang R, Yang YX. Quantitative proteome analysis of ovarian cancer tissues using a iTRAQ approach. J Cell Biochem 113:3762–3772, 2012.
46. Wang LY, Li YG, Chen K, Li K, Qu JL, Qin DD, Tang H. Stable expression and integrated hepatitis B virus genome in a human hepatoma cell line. Genet Mol Res 11:1442–1448, 2012.
47. Wang WB, Levy DE, Lee CK. STAT3 negatively regulates type I IFN-mediated antiviral response. J Immunol 187:2578–2585, 2011.
48. Wu YH, Tseng CP, Cheng ML, Ho HY, Shih SR, Chiu DT. Glucose-6-phosphate dehydrogenase deficiency enhances human coronavirus 229E infection. J Infect Dis 197:812–816, 2008.
49. Xieraili M, Yasen M, Mogushi K, Obulhasim G, Mayinuer A, Aihara A, Tanaka S, Mizushima H, Tanaka H, Arii S. Villin 1 is a predictive factor for the recurrence of high serum alpha-fetoprotein-associated hep-atocellular carcinoma after hepatectomy. Cancer Sci 103:1493–1501, 2012.
50. Yang Y, Lim SK, Choong LY, Lee H, Chen Y, Chong PK, Ashktorab H, Wang TT, Salto-Tellez M, Yeoh KG, Lim YP. Cathepsin S mediates gastric cancer cell migration and invasion via a putative network of metastasis-associated proteins. J Proteome Res 9:4767–4778, 2010.
51. Yang ZF, Ho DW, Lam CT, Luk JM, Lum CT, Yu WC, Poon RT, Fan ST. Identification of brain-derived neurotrophic factor as a novel functional protein in hepatocellular carcinoma. Cancer Res 65:219–225, 2005.
52. Yeo M, Na YM, Kim DK, Kim YB, Wang HJ, Lee JA, Cheong JY, Lee KJ, Paik YK, Cho SW. The loss of phenol sulfotransferase 1 in hepato-cellular carcinogenesis. Proteomics 10:266–276, 2010.
53. Zhang C, Zhang Z, Zhu Y, Qin S. Glucose-6-phosphate dehydrogenase:a biomarker and potential therapeutic target for cancer. Anticancer Agents Med Chem 14:280–289, 2014.
54. Zhang H, Li H, Yang Y, Li S, Ren H, Zhang D, Hu H. Differential regulation of host genes including hepatic fatty acid synthase in HBV-transgenic mice. J Proteome Res 12:2967–2979, 2013.
55. Zhang L, Fogg DK, Waisman DM. RNA interference-mediated silencing of the S100A10 gene attenuates plasmin generation and invasiveness of Colo 222 colorectal cancer cells. J Biol Chem 279:2053–2062, 2004.